Detroit, MINCT06269510Now EnrollingIRB Ready

Alcohol-related Liver Disease Clinical Trial in Detroit, MI

Access cutting-edge alcohol-related liver disease treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.

Sponsored by Henry Ford Health System

Quick Self-Assessment

See if you qualify for this Detroit location

Preparing your pre-screening questions…

Expert Care in Detroit

Access alcohol-related liver disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related alcohol-related liver disease treatment provided free

Apply for This Detroit Location

Check if you qualify for this alcohol-related liver disease clinical trial in Detroit, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Detroit

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Detroit site if eligible
  4. 4Begin participation

About This Alcohol-related Liver Disease Study in Detroit

The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.

Sponsor: Henry Ford Health System

Who Can Participate

Inclusion Criteria

Willingness to comply with all study procedures and availability for the duration of the study
Willing and able to provide informed consent
Enrolled at University of Michigan (UM) hepatology clinics or inpatients at UM Hospitals
Documented diagnosis of alcohol-related liver disease (ALD) (per protocol)
Recent alcohol use of any amount within the past 6 months as assessed by either patient interview, medical chart review, or positive alcohol biomarker (e.g. blood alcohol level, urinary ethyl glucuronide, urinary ethyl sulfate, or phosphatidylethanol) in the medical record.
No alcohol use treatment within the past 1 month including, but not limited to:
Any professionally lead therapy with a mental health counselor (such as, one-on-one therapy, group therapy, couples or family therapy) with a primary aim of alcohol abstinence or reduction in alcohol use.
Community-based alcohol recovery groups (such as, Alcoholics Anonymous, SMART Recovery, Celebrate Recovery, Refuge Recovery)
Community-based church support groups primarily focused on alcohol abstinence or reduction in use.
Residential (inpatient) alcohol treatment
Intensive outpatient programs
Any telehealth version of the above options
Access to a Smartphone or computer for purposes of follow-up. Those who do not have a Smartphone will be provided one along with a calling/data plan at no cost to subject by the study team for the duration of the research stud.
Ability to speak and comprehend English

Exclusion Criteria

Unable to provide voluntary informed consent for any reason
Substantially cognitively impaired as evidenced by Westhaven grade 2 or higher hepatic encephalopathy or a score \>=10 on the Short Blessed Test for cognitive impairment.
Unable to read or understand English
Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation
Is enrolled in the multidisciplinary ALD clinic at Michigan Medicine
Any other medical condition or circumstance that precludes safe and meaningful participation in the study
History of nonadherence to previous clinical or research studies

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Detroit?

Yes, this clinical trial (NCT06269510) has an active research site in Detroit, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Alcohol-related Liver Disease Treatment Options in Detroit, MI

If you're searching for alcohol-related liver disease treatment options in Detroit, MI, this clinical trial (NCT06269510) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alcohol-related liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all alcohol-related liver disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Detroit, MI

See all ankylosing spondylitis clinical trials recruiting in Detroit — not just this study.

Browse Ankylosing Spondylitis Trials in Detroit →

Ready to Join in Detroit?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Detroit, MI